Literature DB >> 28670594

Intravascular Papillary Endothelial Hyperplasia of the Jejunum as a Cause of Obscure-Overt Gastrointestinal Bleeding.

Jonathan Gotfried1, Raul Berio Dorta2, Jennifer Maranki3.   

Abstract

Intravascular papillary endothelial hyperplasia (IPEH), or Masson's tumor, is a rare, benign vascular lesion characterized by reactive endothelial proliferation with venous stasis and thrombus. Lesions typically arise in vascular regions of the head and neck or extremities, but involvement of other organ systems has been reported. Clinically, IPEH mimics other benign lesions (hemangiomas) and malignant neoplasms (angiosarcoma) depending on the affected site. Diagnosis is essential because local excision of certain IPEH subtypes is curative. IPEH in the gastrointestinal tract is rare with few reported cases. We present a case of obscure-overt gastrointestinal bleeding from IPEH of the jejunum.

Entities:  

Year:  2017        PMID: 28670594      PMCID: PMC5482909          DOI: 10.14309/crj.2017.80

Source DB:  PubMed          Journal:  ACG Case Rep J        ISSN: 2326-3253


Introduction

Intravascular papillary endothelial hyperplasia (IPEH) is a rare, benign vascular lesion that usually occurs in the head and neck or extremities. IPEH is a reactive process of endothelial proliferation around thrombi in the setting of venous stasis.1 IPEH can occur in other organ systems, and clinical manifestations depend on the affected site. Six cases of IPEH of the small intestine have been reported.2-6

Case Report

A 43-year-old woman presented with 2 days of nausea, vomiting, and abdominal pain. She had a history of endometrial cancer at stage IB in remission for 3 years and provoked pulmonary embolism 3 years prior to presentation, for which she had completed 6 months of oral anticoagulation. Immediately prior to presentation, she had one episode of melena followed by hematochezia. She denied nonsteroidal antiinflammatory drug or alcohol use. Vital signs at presentation were stable, and physical examination was unremarkable for stigmata of liver disease. Initial hemoglobin was 9.8 g/dL and decreased to 6.5 g/dL over 6 hours. An esophagogastroduodenoscopy on the day of admission revealed patchy erythematous mucosa in the gastric fundus without an identified source of bleeding. She remained stable and underwent colonoscopy on hospital day 2 that found old blood throughout the entire examined colon and terminal ileum without a localized source of bleeding. Early on hospital day 3, the patient experienced an isolated, self-limited episode of hematochezia and hypotension and received 2 units of packed red blood cells. As the patient stabilized following transfusion, a decision was made to proceed with upper double-balloon enteroscopy (DBE) for the initial evaluation of suspected small bowel bleeding. A bleeding, proximal jejunal mass 3 cm in size was identified as the source of bleeding (Figure 1). Biopsies of the lesion were not obtained due to concern of bleeding risk given the vascular appearance of the lesion. The area adjacent to the mass was tattooed in anticipation of surgical removal.
Figure 1

DBE revealing a large, vascular, oozing mass in the jejunum.

DBE revealing a large, vascular, oozing mass in the jejunum. The patient remained stable and underwent laparotomy on hospital day 4. A segment of tattooed bowel was identified 30 cm distal to the ligament of Treitz, and successful resection and primary anastomosis was performed. Macroscopic examination of the specimen revealed a single, 3-cm polyp with adjacent mucosal edema and hemorrhage. Examination of a frozen section revealed focal transmural hemorrhage and surrounding histiocytic reaction favoring a vascular etiology. Microscopic examination demonstrated focal transmural hemorrhage with endothelial papillary proliferation and hyalinized fibrous cores, consistent with IPEH. There was no evidence of malignancy (Figure 2). The patient’s postoperative course was uneventful, and she was discharged in stable condition with regular primary care follow up.
Figure 2

(A) Areas of hemorrhage and thrombus juxtaposed to areas with collagenized structures and ingrowth of endothelium (arrows). (B) Intravascular papillary endothelial hyperplasia showing papillary formation with hyaline stalks covered by plump endothelial cells (arrows). There was no significant nuclear atypia, tumor cell necrosis, or mitotic activity to suggest angiosarcoma.

(A) Areas of hemorrhage and thrombus juxtaposed to areas with collagenized structures and ingrowth of endothelium (arrows). (B) Intravascular papillary endothelial hyperplasia showing papillary formation with hyaline stalks covered by plump endothelial cells (arrows). There was no significant nuclear atypia, tumor cell necrosis, or mitotic activity to suggest angiosarcoma.

Discussion

IPEH is a rare, benign, vascular lesion likely resulting from reactive endothelial proliferation in response to vascular stasis or trauma. First described by Masson in 1923, the entity was hypothesized to be a neoplasm with associated thrombi.7 In 1932, Henschen clarified the disease to be reactive in nature with endothelialization around fragments of thrombi.8 In 1976, Clearkin and Enzinger termed the condition “intravascular papillary endothelial hyperplasia,” reflecting the likely pathophysiology.9 IPEH is categorized into three types: pure, mixed, and extravascular. The pure form occurs de novo in a dilated vascular space with no causative etiology; the mixed form is a superimposed lesion over a preexisting vascular abnormality (arteriovenous malformation or hemangioma); and the extravascular form, which is least common, occurs with endothelial proliferation at a hematoma after trauma. Depending on the affected site, clinical features of IPEH may mimic other benign (hemangiomas, pyogenic granuloma), infectious (bacillary angiomatosis, Kaposi’s sarcoma), or malignant lesions (angiosarcoma). IPEH usually occurs in the vascular regions of the head and neck or in extremities, although other organ systems have been reported. A literature review revealed 23 reported cases of IPEH arising within the abdominal cavity, including the urogenital tract, retroperitoneum, adrenal glands, and liver.10-13 Six cases of IPEH within the gastrointestinal lumen have been reported: 2 in the duodenum and 4 in the jejunum. A possible hormonal etiopathogenesis of IPEH has been proposed in previous reports.5,14 The higher incidence in females with IPEH further supports this hypothesis. The subtype of IPEH in our case is unknown, as a hypercoagulable workup and exclusion of endometrial cancer recurrence were not done during the patient’s stay. Our patient's lesion was directly visualized during upper DBE. A case of IPEH diagnosed with video capsule endoscopy was recently reported.4 While video capsule endoscopy and angiography are available at our institution, DBE was utilized given its immediate availability at the time of the patient’s bleeding episode and response to resuscitation. DBE allowed us to mark the lesion in anticipation of surgical removal and exclude synchronous lesions. Prognosis varies between IPEH types, with the pure IPEH type considered curative after complete removal whereas recurrence has been reported with mixed types.1 As this case illustrates, clinicians should be careful during the workup of obscure-overt gastrointestinal bleeds and consider IPEH when treating those patients. Prompt identification and resection is curative, with low rates of recurrence and excellent patient outcomes in most cases.

Disclosures

Author contributions: All authors contributed equally to the manuscript. J. Maranki is the article guarantor. Financial disclosure: None to report. Attempts to contact the patient for consent were unsuccessful. All identifying information has been removed to protect patient privacy. Acknowledgements: The authors wish to thank Gary Kirshenbaum, MD, Clinical Professor of Pathology at Advocate Illinois Masonic Medical Center for pathology support.
  11 in total

1.  Masson's tumor of the kidney: a new renal lesion.

Authors:  B B Garber; A J Prestipino; H M Pollack; S R Levine; K E Whitmore
Journal:  J Urol       Date:  1990-02       Impact factor: 7.450

2.  Intravascular papillary endothelial hyperplasia.

Authors:  K P Clearkin; F M Enzinger
Journal:  Arch Pathol Lab Med       Date:  1976-08       Impact factor: 5.534

3.  Intravascular papillary endothelial hyperplasia of the adrenal gland.

Authors:  A Kawashima; T Johsen; S Murayama; W J Russell
Journal:  Br J Radiol       Date:  1986-06       Impact factor: 3.039

4.  [Arteriovenous malformation associated with intravascular papillary endothelial hyperplasia in jejunal region. A case report (author' transl)].

Authors:  S Okauchi; N Kurooka; J Nagata; R Yamasaki; T Konoike; F Korai; T Sano; K Ii
Journal:  Rinsho Hoshasen       Date:  1982-01

5.  Intravascular papillary endothelial hyperplasia of the jejunum: an unusual cause of melena.

Authors:  Sarra Mestiri; Mehdi Karoui; Antoine Charachon; Jean-François Deux; Marie-Thérèse Chaumette
Journal:  Int J Surg Pathol       Date:  2007-04       Impact factor: 1.271

6.  Intraabdominal Intravascular Papillary Endothelial Hyperplasia (Masson's Tumor): A Rare and Novel Cause of Gastrointestinal Bleeding.

Authors:  Michael C Meadows; Xiu Sun; Michael Dardik; Deborah R Tarantino; Ronald S Chamberlain
Journal:  Case Rep Gastroenterol       Date:  2010-03-20

7.  Intravascular papillary endothelial hyperplasia. A clinicopathologic study of 91 cases.

Authors:  H Hashimoto; Y Daimaru; M Enjoji
Journal:  Am J Dermatopathol       Date:  1983-12       Impact factor: 1.533

Review 8.  Florid extravascular papillary endothelial hyperplasia (Masson's pseudoangiosarcoma) presenting as a soft-tissue sarcoma.

Authors:  M R Pins; D I Rosenthal; D S Springfield; A E Rosenberg
Journal:  Arch Pathol Lab Med       Date:  1993-03       Impact factor: 5.534

9.  Paroxysmal nocturnal hemoglobinuria associated with venous thrombosis and papillary endothelial hyperplasia presenting as ulcerated duodenal mass.

Authors:  C H Dunphy; C Sotelo-Avila; A Luisiri; J Y Chu
Journal:  Arch Pathol Lab Med       Date:  1994-08       Impact factor: 5.534

10.  Intravascular papillary endothelial hyperplasia (Masson's hemangioma) of the liver: a new hepatic lesion.

Authors:  Seok-Gi Hong; Hyeon-Min Cho; Hyung-min Chin; Il-Young Park; Jin-Young Yoo; Sung-Soo Hwang; Jun-Gi Kim; Woo-Bae Park; Chung-Soo Chun
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more
  1 in total

1.  Intravascular papillary endothelial hyperplasia in the cecum: a case report.

Authors:  Tomoyoshi Endo; Hidetoshi Katsuno; Kenji Kikuchi; Takayuki Ochi; Kazuhiro Matsuo; Kazumitsu Suzuki; Hironobu Yasuoka; Yuko Nakano; Mitsuru Nakagawa; Makoto Kuroda; Zenichi Morise
Journal:  Surg Case Rep       Date:  2022-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.